163
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke

, , , , &
Pages 2299-2306 | Published online: 03 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fariborz Ghaffarpasand, Saeed Torabi, Ali Rasti, Mohammad Hadi Niakan, Sara Aghabaklou, Fatemeh Pakzad, Maryam Sadat Beheshtian & Reza Tabrizi. (2019) Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis. Neuropsychiatric Disease and Treatment 15, pages 127-135.
Read now
Zefeng Wang, Ligen Shi, Shenbin Xu & Jianmin Zhang. (2017) Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials. Drug Design, Development and Therapy 11, pages 1273-1282.
Read now
Nasim Arjmand & Mohammad Reza Dehghani. (2016) Complete blood cell count components and coronary slow-flow phenomenon. Therapeutics and Clinical Risk Management 12, pages 1827-1829.
Read now

Articles from other publishers (10)

Dafin F. Mureșanu, Livia Livinț Popa, Diana Chira, Victor Dăbală, Elian Hapca, Irina Vlad, Vitalie Văcăraș, Bogdan Ovidiu Popescu, Răzvan Cherecheș, Ștefan Strilciuc & Michael Brainin. (2022) Role and Impact of Cerebrolysin for Ischemic Stroke Care. Journal of Clinical Medicine 11:5, pages 1273.
Crossref
Stefan Strilciuc, László Vécsei, Dana Boering, Aleš Pražnikar, Oliver Kaut, Peter Riederer & Leontino Battistin. (2021) Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals 14:12, pages 1297.
Crossref
Beghi Ettore, Binder Heinrich, Birle Codruta, Bornstein Natan, Karin Diserens, Stanislav Groppa, Volker Homberg, Vitalie Lisnic, Maura Pugliatti, Gary Randall, Leopold Saltuari, Stefan Strilciuc, Johannes Vester & Dafin Muresanu. (2021) European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischemic stroke (Translated from English by Natalia Kuprinenko). Ukrains'kyi Visnyk Psykhonevrolohii:Volume 29, issue 3(108), pages 63-76.
Crossref
Brian Fiani, Claudia Covarrubias, Amelia Wong, Thao Doan, Taylor Reardon, Daniel Nikolaidis & Erika Sarno. (2021) Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurological Sciences 42:4, pages 1345-1353.
Crossref
V.V. Zakharov, N.V. Vakhnina & A.G. Gogoleva. (2021) The criteria for effectiveness of reperfusion therapy and neuroprotective therapy in ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:4, pages 86.
Crossref
Peter Y. M. Woo, Joanna W. K. Ho, Natalie M. W. Ko, Ronald P. T. Li, Leo Jian, Alberto C. H. Chu, Marco C. L. Kwan, Yung Chan, Alain K. S. Wong, Hoi-Tung Wong, Kwong-Yau Chan & John C. K. Kwok. (2020) Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage. BMC Neurology 20:1.
Crossref
Liliya Eugenevna Ziganshina, Tatyana Abakumova & Charles HV Hoyle. (2020) Cerebrolysin for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2020:9.
Crossref
A. N. Bogolepova. (2019) Possibilities of neurotrophic therapy in early recovery after stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:8, pages 84.
Crossref
Vimala N. Bharadwaj, Duong T. Nguyen, Vikram D. Kodibagkar & Sarah E. Stabenfeldt. (2017) Nanoparticle‐Based Therapeutics for Brain Injury. Advanced Healthcare Materials 7:1, pages 1700668.
Crossref
Danfeng Zhang, Yan Dong, Ya Li, Jigang Chen, Junyu Wang & Lijun Hou. (2017) Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. BioMed Research International 2017, pages 1-10.
Crossref